162 related articles for article (PubMed ID: 35192151)
21. Melanocortin signaling is decreased during neurotoxin-induced transient hyperphagia and increased body-weight gain.
Dube MG; Pu S; Kalra SP; Kalra PS
Peptides; 2000 Jun; 21(6):793-801. PubMed ID: 10958999
[TBL] [Abstract][Full Text] [Related]
22. Novel homozygous leptin receptor mutation in an infant with monogenic obesity.
Boro H; Bundela V; Mannar V; Nagendra L; Jain V; Jain B; Kumar S; Agstam S
Pediatr Endocrinol Diabetes Metab; 2023; 29(2):118-123. PubMed ID: 37728464
[TBL] [Abstract][Full Text] [Related]
23. Rare genetic forms of obesity: From gene to therapy.
Clément K; Mosbah H; Poitou C
Physiol Behav; 2020 Dec; 227():113134. PubMed ID: 32805220
[TBL] [Abstract][Full Text] [Related]
24. Setmelanotide: what does it mean for clinical care of patients with obesity?
Ryan DH
Lancet Diabetes Endocrinol; 2020 Dec; 8(12):933-935. PubMed ID: 33137294
[No Abstract] [Full Text] [Related]
25. Structural analysis of setmelanotide binding to MC4R variants in comparison to wild-type receptor.
Hammad MM; Mohammad A; Alam-Eldin N; Madhu D; Al-Mulla F; Abu-Farha M; Abubaker J
Life Sci; 2022 Oct; 307():120857. PubMed ID: 35931197
[TBL] [Abstract][Full Text] [Related]
26. The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alström syndrome: Phase 3 trial design.
Haws RM; Gordon G; Han JC; Yanovski JA; Yuan G; Stewart MW
Contemp Clin Trials Commun; 2021 Jun; 22():100780. PubMed ID: 34013094
[TBL] [Abstract][Full Text] [Related]
27. The Narrative of a Patient with Leptin Receptor Deficiency: Personalized Medicine for a Rare Genetic Obesity Disorder.
Welling MS; Kleinendorst L; van Haelst MM; van den Akker ELT
Obes Facts; 2023; 16(5):514-518. PubMed ID: 37393902
[TBL] [Abstract][Full Text] [Related]
28. The melanocortin pathway and energy homeostasis: From discovery to obesity therapy.
Yeo GSH; Chao DHM; Siegert AM; Koerperich ZM; Ericson MD; Simonds SE; Larson CM; Luquet S; Clarke I; Sharma S; Clément K; Cowley MA; Haskell-Luevano C; Van Der Ploeg L; Adan RAH
Mol Metab; 2021 Jun; 48():101206. PubMed ID: 33684608
[TBL] [Abstract][Full Text] [Related]
29. Leptin receptor-positive and leptin receptor-negative proopiomelanocortin neurons innervate an identical set of brain structures.
Lima LB; Metzger M; Furigo IC; Donato J
Brain Res; 2016 Sep; 1646():366-376. PubMed ID: 27321158
[TBL] [Abstract][Full Text] [Related]
30. Pro-opiomelanocortin (POMC) deficiency and peripheral melanocortins in obesity.
Zemel MB; Shi H
Nutr Rev; 2000 Jun; 58(6):177-80. PubMed ID: 10885325
[TBL] [Abstract][Full Text] [Related]
31. Hormone-Replacement Therapy for Melanocyte-Stimulating Hormone Deficiency.
Reitman ML
N Engl J Med; 2016 Jul; 375(3):278-9. PubMed ID: 27468065
[No Abstract] [Full Text] [Related]
32. Functional characterization of all missense variants in
Shah BP; Sleiman PM; Mc Donald J; Moeller IH; Kleyn P
Expert Rev Endocrinol Metab; 2023 Mar; 18(2):209-219. PubMed ID: 36864747
[TBL] [Abstract][Full Text] [Related]
33. Two Cases With an Early Presented Proopiomelanocortin Deficiency-A Long-Term Follow-Up and Systematic Literature Review.
Gregoric N; Groselj U; Bratina N; Debeljak M; Zerjav Tansek M; Suput Omladic J; Kovac J; Battelino T; Kotnik P; Avbelj Stefanija M
Front Endocrinol (Lausanne); 2021; 12():689387. PubMed ID: 34177811
[TBL] [Abstract][Full Text] [Related]
34. A rapidly acting glutamatergic ARC→PVH satiety circuit postsynaptically regulated by α-MSH.
Fenselau H; Campbell JN; Verstegen AM; Madara JC; Xu J; Shah BP; Resch JM; Yang Z; Mandelblat-Cerf Y; Livneh Y; Lowell BB
Nat Neurosci; 2017 Jan; 20(1):42-51. PubMed ID: 27869800
[TBL] [Abstract][Full Text] [Related]
35. Metabolic Precision Medicines: Curing POMC Deficiency.
Müller TD; Tschöp MH; O'Rahilly S
Cell Metab; 2016 Aug; 24(2):194-5. PubMed ID: 27452145
[TBL] [Abstract][Full Text] [Related]
36. The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis.
Ellacott KL; Cone RD
Recent Prog Horm Res; 2004; 59():395-408. PubMed ID: 14749511
[TBL] [Abstract][Full Text] [Related]
37. Collective and individual functions of leptin receptor modulated neurons controlling metabolism and ingestion.
van de Wall E; Leshan R; Xu AW; Balthasar N; Coppari R; Liu SM; Jo YH; MacKenzie RG; Allison DB; Dun NJ; Elmquist J; Lowell BB; Barsh GS; de Luca C; Myers MG; Schwartz GJ; Chua SC
Endocrinology; 2008 Apr; 149(4):1773-85. PubMed ID: 18162515
[TBL] [Abstract][Full Text] [Related]
38. Setmelanotide: A Novel Targeted Treatment for Monogenic Obesity.
Pressley H; Cornelio CK; Adams EN
J Pharm Technol; 2022 Dec; 38(6):368-373. PubMed ID: 36311304
[No Abstract] [Full Text] [Related]
39. [Melanocortin peptides : Fundamentals, translational research, clinical dermatology, and future perspectives].
Böhm M
Hautarzt; 2020 Oct; 71(10):741-751. PubMed ID: 32880662
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]